Key questions as EU watchdog rules on AstraZeneca

Burden of disability in children and adolescents must be integrated into the global health agenda
18 March 2021
Seven days in medicine: 10-16 March 2021
18 March 2021

Key questions as EU watchdog rules on AstraZeneca

The EU’s drug regulator, the European Medicines Agency, finds itself in the hot seat on Thursday when it will decide what to do about blood clot fears over the AstraZeneca coronavirus jab.

Comments are closed.